Announced Fri, 5 Dec · 17:04 IST

Postponment of the meeting of the Right Issue Committe of the Welcure Drugs and Pharmaceuticals Limited which was to be held today i.e Monday,December 05,2025

Record Date RevisedCorporate Actions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Welcure Drugs & Pharmaceuticals has postponed the meeting of its Rights Issue Committee that was originally scheduled for December 5, 2025. The meeting was supposed to decide key terms of the upcoming rights issue, including the record date, issue price, and entitlement ratio. The delay is because the company is still waiting for in-principle approval from BSE for the rights issue. The committee will now meet on the next working day after receiving this approval from the stock exchange. This is purely a procedural delay, and the rights issue itself is not cancelled.

Likely market impact

Shareholders will have to wait a little longer for clarity on the rights issue terms such as issue price and record date. The stock may see some short-term uncertainty, but the underlying rights issue plan remains intact pending only stock exchange approval.